Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Hair transplants make people look more attractive, successful, approachable, and younger.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Both genetic and lifestyle factors significantly affect female hair loss.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

People with more knowledge about their hair loss condition and those who see it as a serious issue are more likely to seek treatment.

Only 22% of teenage girls in the study knew about PCOS, despite many having symptoms.

Adding cells to fat grafts improves hair regrowth in early baldness, but effects lessen over time.

Saw palmetto supplements may modestly improve hair regrowth with few side effects, but more research is needed.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Obesity is linked to skin conditions like acanthosis nigricans and skin tags, which may indicate high insulin levels.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

PCOS affects nearly 25% of female medical and dental students, impacting their academic and social lives.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.